Screener
Phathom Pharmaceuticals, Inc. PHAT Return on equity
Discontinued — last reported Q1 '22
Return on equity at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed May 10, 2022. Open the filing →
- Filed
- May 10, 2022, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2022
- Calendar quarter
- Q1 2022
- Accession
- 0000950170-22-008741
FAQ
- What is Phathom Pharmaceuticals, Inc.'s return on equity?
- Phathom Pharmaceuticals, Inc. (PHAT) reported return on equity of -147.9% in Q1 2022.
- What does return on equity mean?
- Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.
Ask your AI about Phathom Pharmaceuticals, Inc.'s return on equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude